{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:35:06Z","timestamp":1793385306704,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","injuryjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Injury"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.injury.2020.10.087","type":"journal-article","created":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T13:02:27Z","timestamp":1603112547000},"page":"1423-1428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Risk factors for atypical forearm fractures associated with bisphosphonate usage"],"prefix":"10.1016","volume":"52","author":[{"given":"Soo Min","family":"Cha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4290-1125","authenticated-orcid":false,"given":"Hyun Dae","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.injury.2020.10.087_bib0001","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S8756-3282(00)00376-8","article-title":"Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women","volume":"27","author":"Boivin","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.injury.2020.10.087_bib0002","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa030897","article-title":"Ten years\u2019 experience with alendronate for osteoporosis in postmenopausal women","volume":"350","author":"Bone","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.injury.2020.10.087_bib0003","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1359\/jbmr.2003.18.6.1051","article-title":"Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate","volume":"18","author":"Eastell","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.injury.2020.10.087_bib0004","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.bone.2006.04.028","article-title":"Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate","volume":"39","author":"Allen","year":"2006","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.injury.2020.10.087_bib0005","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00198-014-2885-0","article-title":"Ulnar fractures with bisphosphonate therapy: a systematic review of published case reports","volume":"26","author":"Tan","year":"2015","journal-title":"Osteoporos Int"},{"issue":"8","key":"10.1016\/j.injury.2020.10.087_bib0006","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1007\/s00198-014-2739-9","article-title":"Stress fracture of the ulna associated with bisphosphonate therapy and use of walking aid","volume":"25","author":"Chiang","year":"2014","journal-title":"Osteoporos Int"},{"issue":"7","key":"10.1016\/j.injury.2020.10.087_bib0007","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00402-013-1760-3","article-title":"Atypical forearm fractures associated with long-term use of bisphosphonate","volume":"133","author":"Moon","year":"2013","journal-title":"Arch Orthop Trauma Surg"},{"issue":"4","key":"10.1016\/j.injury.2020.10.087_bib0008","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s00198-012-2118-3","article-title":"Bilateral ulna fractures associated with bisphosphonate therapy","volume":"24","author":"Ang","year":"2013","journal-title":"Osteoporos Int"},{"issue":"3","key":"10.1016\/j.injury.2020.10.087_bib0009","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1177\/230949901101900323","article-title":"Alendronate-associated ulnar and tibial fractures: a case report","volume":"19","author":"Tang","year":"2011","journal-title":"J Orthop Surg (Hong Kong)"},{"issue":"6","key":"10.1016\/j.injury.2020.10.087_bib0010","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3109\/17453674.2011.636676","article-title":"Atypical fracture of the ulna associated with alendronate use","volume":"82","author":"Bj\u00f8rgul","year":"2011","journal-title":"Acta Orthop"},{"issue":"2","key":"10.1016\/j.injury.2020.10.087_bib0011","first-page":"208","article-title":"Atypical fractures of the femur and ulna and complications of fracture healing in a 76-year-old woman with Sj\u00f6gren's syndrome","volume":"11","author":"Stathopoulos","year":"2011","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"10.1016\/j.injury.2020.10.087_bib0012","article-title":"Treatment of atypical ulnar fractures associated with long-term bisphosphonate therapy for osteoporosis: autogenous bone graft with internal fixation","volume":"2017","author":"Shimada","year":"2017","journal-title":"Case Rep Orthop"},{"issue":"3","key":"10.1016\/j.injury.2020.10.087_bib0013","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4055\/cios.2018.10.3.389","article-title":"Atypical fracture of the proximal shaft of the ulna associated with prolonged bisphosphonate therapy","volume":"10","author":"Oh","year":"2018","journal-title":"Clin Orthop Surg"},{"key":"10.1016\/j.injury.2020.10.087_bib0014","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/450148","article-title":"Prophylactic nailing of incomplete atypical femoral fractures","volume":"2013","author":"Oh","year":"2013","journal-title":"Sci World J"},{"issue":"12","key":"10.1016\/j.injury.2020.10.087_bib0015","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1007\/s11999-010-1583-2","article-title":"Is surgery necessary for femoral insufficiency fractures after long-term bisphosphonate therapy?","volume":"468","author":"Ha","year":"2010","journal-title":"Clin Orthop Relat Res"},{"issue":"6","key":"10.1016\/j.injury.2020.10.087_bib0016","doi-asserted-by":"crossref","first-page":"e954","DOI":"10.3928\/01477447-20120525-41","article-title":"Prophylactic intramedullary fixation for bisphosphonate-related subtrochanteric stress fracture","volume":"35","author":"Fowler","year":"2012","journal-title":"Orthopedics"},{"key":"10.1016\/j.injury.2020.10.087_bib0017","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4065\/81.8.1013","article-title":"Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases","volume":"81","author":"Siris","year":"2006","journal-title":"Mayo Clin Proc"},{"issue":"11","key":"10.1016\/j.injury.2020.10.087_bib0018","first-page":"1084","article-title":"Bisphosphonates and atypical femoral fractures","volume":"363","author":"Hofbauer","year":"2010","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.injury.2020.10.087_bib0019","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMc1006621","article-title":"Bisphosphonates and atypical femoral fractures","volume":"363","author":"Silverman","year":"2010","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.injury.2020.10.087_bib0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11864-019-0623-8","article-title":"Role of bisphosphonates in breast cancer therapy","volume":"20","author":"Goldvaser","year":"2019","journal-title":"Curr Treat Options Oncol"},{"issue":"1","key":"10.1016\/j.injury.2020.10.087_bib0021","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/cncr.11892","article-title":"Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion","volume":"100","author":"Rosen","year":"2004","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.injury.2020.10.087_bib0022","first-page":"377","article-title":"Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial","volume":"7","author":"Rosen","year":"2001","journal-title":"Cancer J"},{"issue":"2","key":"10.1016\/j.injury.2020.10.087_bib0023","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1200\/JCO.2001.19.2.558","article-title":"Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials","volume":"19","author":"Major","year":"2001","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.injury.2020.10.087_bib0024","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.bone.2012.05.010","article-title":"Atypical femur fractures among breast cancer and multiple myeloma patients receiving intravenous bisphosphonate therapy","volume":"51","author":"Chang","year":"2012","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.injury.2020.10.087_bib0025","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4048\/jbc.2012.15.2.261","article-title":"Atypical subtrochanteric femur fracture in patient with metastatic breast cancer treated with zoledronic acid","volume":"15","author":"Kim","year":"2012","journal-title":"J Breast Cancer"},{"issue":"5","key":"10.1016\/j.injury.2020.10.087_bib0026","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/RLU.0000000000002058","article-title":"Impending atypical femoral fracture in a patient of breast cancer with bone metastases receiving long-term denosumab","volume":"43","author":"Sugihara","year":"2018","journal-title":"Clin Nucl Med"},{"issue":"2","key":"10.1016\/j.injury.2020.10.087_bib0027","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/GME.0b013e31829ef343","article-title":"Use of drug holidays in women taking bisphosphonates","volume":"21","author":"Diab","year":"2014","journal-title":"Menopause"},{"issue":"6","key":"10.1016\/j.injury.2020.10.087_bib0028","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s00198-018-4506-9","article-title":"A proposal for an atypical femur fracture treatment and prevention clinical practice guideline","volume":"29","author":"Dell","year":"2018","journal-title":"Osteoporos Int"}],"container-title":["Injury"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0020138320309074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0020138320309074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T06:34:42Z","timestamp":1758090882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0020138320309074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0020138320309074"],"URL":"https:\/\/doi.org\/10.1016\/j.injury.2020.10.087","relation":{},"ISSN":["0020-1383"],"issn-type":[{"value":"0020-1383","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for atypical forearm fractures associated with bisphosphonate usage","name":"articletitle","label":"Article Title"},{"value":"Injury","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.injury.2020.10.087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}